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Background: Cocaine-dependent individuals (CDI) present executive cognitive function
(ECF) deficits, but the impact of psychiatric comorbidities such as Attention-Deficit Hyper-
activity Disorder (ADHD) on neuropsychological functioning is still poorly understood. The
aim of this study was to investigate if CDI with ADHD (CDI+ADHD) would have a distinct
pattern of executive functioning when compared with CDI without ADHD (CDI).
Methods: We evaluated 101 adults, including 69 cocaine-dependent subjects (divided in
CDI and CDI+ADHD) and 32 controls. ECF domains were assessed with Digits Forward
(DF), Digits Backward (DB), Stroop Color Word Test (SCWT), the Wisconsin Card Sorting
Test (WCST), and the Frontal Assessment Battery (FAB). DSM-IV criteria for ADHD were
used for diagnosis and previous ADHD symptoms (in the childhood) were retrospectively
assessed by the Wender-Utah Rating Scale (WURS).
Results:There were no significant differences between CDI+ADHD, CDI, and controls in
estimated intellectual quotient (IQ), socioeconomic background, education (in years), and
pre-morbid IQ (p>0.05). SCWT and WCST scores did not differ across groups (p>0.05).
Nevertheless, CDI and CDI+ADHD performed more poorly than controls in total score of
the FAB (p<0.05). Also, CDI+ADHD did worse than CDI on DF (F =4.756, p=0.011), DB
(F =8.037, p=0.001), Conceptualization/FAB (F =4.635, p=0.012), and Mental flexibil-
ity/FAB (F =3.678, p=0.029). We did not find correlations between cocaine-use variables
and neuropsychological functioning, but previous ADHD symptoms assessed by WURS
were negatively associated with DF (p=0.016) and with the total score of the FAB
(p=0.017).
Conclusion: CDI+ADHD presented more pronounced executive alterations than CDI and
CDI exhibited poorer cognitive functioning than controls. Pre-existing ADHD symptoms
may have a significant negative impact on executive dysfunction in CDI. It remains to be
investigated by future studies if symptoms such as impulsivity or a pre-existing ECF dys-
function could represent underlying cognitive endophenotypes that would substantially
increase the risk for acquiring addictive disorders.
Keywords: executive dysfunction, ADHD, cocaine, addiction, impulsivity, prefrontal cortex
INTRODUCTION
There is accumulating evidence from cognitive neuroscience
research that cocaine-dependent individuals (CDI) present pre-
frontal cortex (PFC) functional and structural abnormalities (1–
5), which are associated with executive cognitive function (ECF)
deficits (6–8). Data suggest that regional metabolic alterations seen
in CDI are associated with changes in brain dopamine activity
(2, 9, 10) as well as with neuronal injury in the frontal cortex
in both frontal gray and white matter (5, 11–13). There are also
several studies showing that chronic cocaine-use is associated with
attention, memory, and executive impairments (7, 14–19).
Our research group has shown that cocaine-use is associated
with hypoperfusion in several areas of the brain (3) and that
CDI present several cognitive impairments which have real-life
implications (16–18). We have recently evaluated 30 CDI, after
2 weeks of abstinence, and compared with 32 healthy individu-
als in frontal executive tasks. CDI performed more poorly than
controls in digits forward (DF), digits backward (DB), and on the
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Frontal Assessment Battery (FAB) (17). The FAB is a brief neu-
ropsychological battery devised by neurologists, composed of six
subtests which evaluate different ECF-related functions (20). The
performance on the six subtests of the FAB gives a global score
suggesting a “descriptive pattern of ECF in a given patient” (20).
In our study, CDI were cognitively impaired in 50% (3/6) of the
cognitive domains assessed by the FAB: abstract reasoning, motor
planning, and cognitive flexibility. The results on the FAB were cor-
related with traditional frontal/executive tasks, showing that the
FAB is a good indicator of severity of the executive dysfunction in
CDI. Another recent study from our group aimed to investigate a
possible link between ECF-related tasks and what happens in the
real social life of CDI. The results indicated that impaired ECF in
CDI was correlated with their higher levels of social dysfunction, in
several areas of the social domain, including work, leisure, family,
and finances (18). The relevance of executive dysfunction in CDI is
also justified because ECF-related impairments are associated with
poor treatment retention in cognitive-behavioral therapy (CBT)
(21, 22) and with relapses (23).
However, it is difficult to determine to what extent the sub-
stance per se leads to ECF alterations through its influence on brain
functioning, or if the ECF deficits would represent pre-morbid
factors which may lead to stimulant dependence (5) and to more
intense neuropsychological deficits. According to recent studies,
ECF impairments may be both predisposing factors and/or nega-
tive consequences of CDI (17, 24–27). Fillmore and Rush (27) have
argued that a common cognitive characteristic of CDI is an execu-
tive deficit, which makes them more vulnerable to risky behaviors
and substance abuse. Animal studies also reinforce the hypothe-
sis that a impaired self-control, impulsivity, and ECF alterations
may be candidates neurocognitive endophenotypes that predates
the emergence of addictions (28–30); those symptoms are very
common across disorders such as Attention-Deficit Hyperactivity
Disorder (ADHD) (5, 30).
Attention-deficit hyperactivity disorder is characterized as a
neuropsychiatric disorder, with inattention, hyperactivity, and
impulsivity symptoms (31). ADHD is significantly more prevalent
among CDI than in the general population (32). The high preva-
lence of ADHD among CDI could be a significant confounding
factor for neuropsychological studies, as ADHD per se is associ-
ated with neuropsychological deficits that affect predominantly
ECF and also interfere in daily life activities (33–35). The ADHD
cognitive endophenotype includes deficits in response inhibition
that leads to impulsivity (30, 36), and this is considered a possible
vulnerability marker for cocaine dependence (27). Moreover, it
has been suggested that measures of response inhibition can help
identify genetic susceptibility to ADHD (36).
However, there is not enough evidence to establish if the ECF
deficits are pre-existing factors in CDI, which could lead to real-
life problems and then make the subject more vulnerable to drug
addiction, or if the cocaine-use per se would be the main factor
that impairs ECF leading to the persistence of cocaine-use despite
negative consequences (18). We consider that there is still incon-
sistency regarding the findings of attention and executive deficits
among CDI, due to different methodologies applied and to the
lack of more controlled studies (37). Further studies are necessary
to verify the nature and severity of the attention and executive
deficits associated with cocaine-use, as they have a direct clinical
implication in treatment (6, 7, 16, 32). To date, few studies have
investigated the role of ADHD in cocaine dependence. One study
showed that although cocaine abusers performed significantly
more poorly than controls on several neuropsychological tasks,
there was no significant relationship between measures of child-
hood ADHD symptoms and neuropsychological performance
(38). On the other hand, more recently, it was observed that ADHD
symptoms were important modulators of cognitive function in
CDI, suggesting that cocaine-use and ADHD symptoms seem to
have mutual aggravating effects in executive impairments (19).
Considering that there are still controversies about the role of
ADHD diagnosis in cognitive performance of CDI, our aim was to
evaluate the ECF deficits among CDI and to investigate the impact
of an ADHD diagnosis on these patients. Our hypothesis was
that CDI with ADHD diagnosis would present more pronounced
deficits on ECF and that ADHD symptoms and cocaine-use-
related variables such as age at onset would be correlated with
the degree of ECF deficits in these patients.
MATERIALS AND METHODS
PARTICIPANTS
Hundred and one subjects participated in this study. All the CDI
(with or without ADHD, n= 69) met the DSM-IV-TR criteria (31)
for cocaine dependence at the time of admission to the treatment
program. The CDI were recruited from two inpatient units: (1) the
Interdisciplinary Group of Studies on Alcohol and Drugs (GREA)
at the University of São Paulo (USP); (2) the Association for the
Promotion of Prayer and Work (APOT) in Campinas (SP, Brazil).
Exclusion criteria included were: (1) past or current major DSM
diagnosis of psychotic disorders, or a current diagnosis of bipo-
lar disorders; (2) met DSM criteria for opioid dependence; (3)
had a history of neurological condition such as epilepsy and/or
head injuries with loss of consciousness for longer than 30 min,
strokes and intracranial hemorrhages; (4) had prior diagnosis of
learning disorder; (5) had intellectual quotient (IQ) less than 70.
The CDI were all treatment-seeking cocaine-dependent patients
evaluated after at least 1 week of abstinence. The abstinence was
verified by self-report and supervised by the clinical staff of the
inpatient units. For the majority of these patients (n= 39, 56.5%),
two urine tests were used to verify recent cocaine-use (if posi-
tive) and after to verify their abstinence (if negative), since recent
cocaine-use may mask cognitive impairments in CDI (39). The
neurocognitive performance of the CDI was compared to a con-
trol group which consisted of 32 healthy individuals, who were
volunteers, recruited in the city of São Paulo. The control group
consisted of employes from the public hospital where the research
center (GREA) is located (n= 2) and the local police department
(n= 12). We also recruited adult students from a public school
(n= 18). The transport costs of the volunteers were reimbursed.
The exclusion criteria for the control group were: (1) met DSM
criteria for any psychoactive substance dependence other than
nicotine; (2) the same exclusion criteria of the cocaine group.
PROCEDURES AND ETHICAL CONSIDERATIONS
The data presented in this report were collected between Janu-
ary 2001 and March 2013. The research protocol satisfied the
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Helsinki Declaration and was approved by the University of
Sao Paulo Review Board (CAPPesq). After signing an informed
consent, participants were interviewed by either a clinical psy-
chologist or a psychiatrist. The interview questions covered
demographics, drug use, and the consequences of drug use
on their psychosocial functioning. Investigators obtained ini-
tial demographic and clinical information by a semi-structured
interview used by neuropsychologists at our research center
(17). The semi-structured neuropsychological interview included
basic information such as name, address, gender, age, eth-
nic, handedness, educational background, professional activi-
ties, socioeconomic level, as well as questions about the med-
ical past and current history, neurodevelopmental history, and
neurocognitive complaints associated with cocaine and drug
use (16, 18).
MOOD, ANXIETY, AND DRUG USE EVALUATION
Psychological and psychiatric symptoms were assessed by the
Beck Depression Inventory (BDI) (40) and the State-Trait Anxiety
Inventory (STAI) (41). Alcohol, tobacco,and other drug use,as well
as the consequences of drug use among the cocaine group, were
assessed using the Cocaine Addiction Severity Test (CAST) and
Cocaine Assessment Profile (42) or the ASI-6 Addiction Severity
Index (43).
NEUROPSYCHOLOGICAL MEASURES
Digits forward and backward, from the revised version of the
Wechsler Adult Intelligence Scale
Digits forward was used was used to measure attention span and
DB working memory (44). In DF the examinee needs to repeat a
sequence of random numbers in the same order and DB in the
reverse order (45).
Stroop color word test
It was designed to measure selective attention, cognitive flexibility,
and inhibitory control (45, 46). Here it was used a Stroop color
word test (SCWT) Portuguese version, published elsewhere (17).
Wisconsin card sorting test
The 64 card version (47, 48), translated and validated for use in
Brazil (17, 49). This task evaluates ECF such as: mental flexibility,
abstract reasoning, capacity to maintain the cognitive setting and
self-monitoring (45).
Frontal assessment battery
The administration of the FAB takes approximately 10 min; each
subtest is scored from 0 (minimum score) to 3 (maximum score)
and the total score of the FAB is the sum of the scores in the six sub-
tests (the FAB’s total score ranges from 0 to 18) (20). The FAB was
translated into Portuguese (17, 50) and detailed information about
instructions of the FAB are described elsewhere (20). The six sub-
tests are: conceptualization, mental flexibility, motor programing,
sensitivity to interference, inhibitory control, and environmental
autonomy.
Intellectual functioning
We used short forms of the Wechsler Intelligence Scale for
Adults – Revised [WAIS-R, (44)] and the Wechsler Adult Scale of
Intelligence (WASI) to evaluate an estimated IQ which is a reliable
measure of Full Scale IQ.
OBJECTIVE MEASUREMENT OF ADHD SYMPTOMS AND DIAGNOSIS
Wender-Utah rating scale
It evaluates retrospectively different symptoms of ADHD. Here
we used an abbreviated version of the Wender-Utah Rating Scale
(WURS) comprising 25 of the 61 items from the original scale,
which has shown to better discriminate between patients with
ADHD and a non-patient comparison group (51). Participants
were asked to self-report if they had experienced those ADHD
symptoms during the childhood (until the age of 12 years old) on
a Likert-type scale scored 0 (not at all or very slightly), 1 (mildly),
2 (moderately), 3 (quite a bit), and 4 (very much). The WURS
minimum score is 0 and the maximum score is 100. The total was
calculated and participants were considered as having preexistent
ADHD significant symptoms if they scored 46 or above, which has
shown to be a reliable estimate for ADHD diagnosis in the child-
hood. More specifically, in a validation study, a cutoff score of 46
or higher correctly identified 86% of the patients with ADHD and
99% of the normal subjects (51).
ADHD diagnosis by DSM-IV-TR
It is based in nine symptoms of Inattention and nine symptoms of
Hyperactivity/Impulsivity (31). The patient must fulfill at least six
of nine (six or more) symptoms in each group or in both groups
(Inattention and Hyperactivity/Impulsivity). The symptoms must
have persisted for at least 6 months to a degree that is inconsistent
with developmental level and that impact directly on social and
academic/occupational activities. A requirement for the diagnosis
of ADHD in adults is a childhood history of ADHD which was
measured by WURS (right above).
Definition of CDI+ADHD, CDI, and controls
We only considered subjects in the group called CDI+ADHD if
they had fulfilled both confirmation of the adult ADHD diagnosis
by DSM-IV-TR criteria (31) and if they had a WURS total score
of 46 or higher (51).
STATISTICAL ANALYSES
Differences in performance on neuropsychological tests were
assessed with unpaired t -tests and categorical variables were eval-
uated using Fisher’s exact test. The normal distribution of each
cognitive variable was confirmed by the Kolmogorov–Smirnov
test. The level of statistical significance was α= 0.05 and all sta-
tistical tests were two tailed. Comparative analysis considering
three groups (CDI, CDI+ADHD, and controls) was made using
Analysis of Variance (ANOVA) and Bonferroni post hoc testing.
Additionally, between-group analysis of cognitive functioning was
conducted using Analysis of Covariance (ANCOVA) with age
and gender as covariates. Correlation between neuropsycholog-
ical measures [i.e., DF, DB, SCWT, Wisconsin Card Sorting Test
(WCST), and FAB], cocaine-use variables (i.e., age at onset, absti-
nence, and duration of cocaine-use), and WURS (total score) was
assessed by the Spearman correlation coefficient (r s). All statisti-
cal analyses were conducted using Statistical Package for the Social
Science (SPSS) software version 14.0 for Windows.
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Table 1 | Socio-demographic variables, intellectual functioning, and substance use of the CDI, CDI+ADHD, and healthy controls.
CDI (n=58) CDI+ADHD (n=11) Controls (n=32) p
Age 31.24 (±7.39) 28.64 (±8.27) 26.75 (±5.55) 0.015*
Gender (male/female) 56/2 8/3 32/0 0.001*
Education (years) 11.78 (±3.41) 10.82 (±3.60) 10.78 (±2.20) 0.292
Socioeconomic level
A 10.3% 18.2% 3.1% 0.295
B 48.3% 45.5% 34.4%
C 32.8% 36.4% 43.8%
D 8.6% 0% 18.8%
Ethnicity (Brazilian White/African Brazilian) 18/40 4/7 27/5 0.000*
Handedness (right handed/left-handed/ambidextrous) 52/0/6 10/0/1 26/5/1 0.015*
Estimated intellectual quotient (IQ) 96.36 (±14.11) 93.91 (±16.66) 101.06 (±12.82) 0.210
Vocabulary (WAIS-R or WASI) 49.55 (±12.25) 47.73 (±12.56) 47.31 (±8.79) 0.642
WURS 24.91 (±16.23) 61.73 (±12.58) 13.77 (±14.09) 0.000*
CDI, cocaine-dependent individuals; CDI+ADHD, cocaine-dependent individuals with attention deficit/hyperactivity disorder; SD, Standard Deviation (±); WAIS-R,
Wechsler Adult Intelligence Scale-Revised;WASI,Wechsler Abbreviated Scale of Intelligence;WURS,Wender-Utah Rating Scale; Quantitative variables were compared
using ANOVA and categorical variables were compared using Pearson Chi-Square;*p< 0.05 – statistically significant. Socioeconomic levels were classified according
to Brazilian norms (ABIPEME): A= highest socioeconomic level and D= lowest socioeconomic level.
RESULTS
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS
Socio-demographic and some clinical characteristics of the groups
are described in Table 1.
The three groups did not differ in educational level (in
years), socioeconomic level, estimated IQ, and vocabulary
score. However we found differences among groups regard-
ing age, gender, ethnicity, handedness, and childhood ADHD
scores (WURS). Controls were younger, male, more frequently
white, and left-handed, in comparison to both CDI+ADHD
(n= 11) and CDI (n= 58). CDI+ADHD had significantly
higher WURS scores, followed by CDI and normal controls
(Table 1).
COCAINE, ALCOHOL, AND OTHER SUBSTANCE RECENT USE BY THE CDI
AND CDI+ADHD
Groups with a history of cocaine dependence (CDI and
CDI+ADHD) did not differ significantly in terms of the main
cocaine-use variables, such as age at onset, duration (in years),
and length of abstinence (Table 2). They also showed a simi-
lar pattern of recent use for other substances, such as alcohol,
cannabis, tobacco, heroin, amphetamine, sedatives, and LSD. Dif-
ferences were only detected for alcohol and tobacco recent use
when comparing both groups of patients (CDI and CDI=ADHD)
with controls. There were no differences between the percentages
of cannabis and multiple substance abusers among the groups of
patients.
NEUROPSYCHOLOGICAL FINDINGS
The ANOVA including the three groups (CDI, CDI+ADHD,
and controls) did not show any statistically significant dif-
ference among patients and controls in all measures of
SCWT and WCST. However, groups differed in attention
(DF: F = 4.756, p= 0.011) and in working memory (DB:
F = 8.037, p= 0.001) tasks (Table 3). Post hoc comparisons
Table 2 | Cocaine, alcohol, and other drug use in the CDI and
CDI+ADHD.
CDI (n=58) CDI+ADHD
(n=11)
Controls
(n=32)
p
COCAINE-USE
Age at onset 18.81±4.57 18.27±6.42 – 0.739
Duration (years) 10.71±6.98 8.27±4.38 – 0.270
Abstinence (days) 12.40±9.16 12.09±4.30 – 0.914
ALCOHOLAND OTHER SUBSTANCES (RECENT USE, n)
Alcohol 53.4% 45.5% 9.4% 0.000
Tobacco 69% 81.8% 12.5% 0.000
Cannabis 39.7% 54.5% – 0.278
Heroin 1.7% 0% – 1.000
Amphetamine 1.7% 0% – 1.000
Sedatives 20.7% 27.3% – 0.694
Multiple substance users 27.3% 27.6% – 1.000
CDI, cocaine-dependent individuals; CDI+ADHD, cocaine-dependent individu-
als with attention deficit/hyperactivity disorder; Recent use=was defined as
substance use for at least three times a week in the last 30 days; Quanti-
tative variables (about cocaine-use) were compared using Student t-test for
comparisons among CDI and CDI+ADHD; Categorical variables (about alcohol
and other substances) were compared using Pearson Chi-Square and Fisher’s
Exact Test; *p<0.05 – statistically significant; p refers to comparative analyses
only between CDI and CDI+ADHD except for alcohol and tobacco recent use
(CDI×CDI+ADHD×Controls).
showed that the difference in DF was due to worse perfor-
mance of CDI+ADHD in comparison to both CDI (p= 0.013)
and controls (p= 0.011). CDI did not differ significantly
from controls in this task (DF). Differences in the test
of working memory (DB) were due to a lowered perfor-
mance of both groups of cocaine-dependents (CDI+ADHD
and CDI) when directly and separately compared with
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Table 3 | Performance of CDI, CDI+ADHD, and healthy controls in traditional neuropsychological tests designed to evaluate executive cognitive
functioning (ECF).
Neurocognitive
functions
Neuropsychological tests CDI mean (±SD)
(n=58)
CDI+ADHD mean (±SD)
(n=11)
Controls mean (±SD)
(n=32)
p
Attention and
executive
functioning
SCWT Part I (sec) 14.460±3.63 13.745±2.31 14.58±4.22 0.81
Part II (sec) 17.16±4.21 18.63±4.41 17.29±4.71 0.59
Part III (sec) 26.68±8.68 28.86±9.12 26.08±8.88 0.66
WCST (64-cards) Errors 19.22±9.64 24±11.16 19.78±9.10 0.32
Perseverative errors 9.79±6.18 12.91±7.71 10.22±5.57 0.31
Failure to maintain set 0.71±0.84 0.27±0.47 0.63±0.79 0.25
Categories* 2.83±1.27 2.36±1.80 2.72±1.30 0.57
Digits (WAIS-R) Forward (DF) 6.45±1.97 4.36±2.33 6.63±2.51 0.01*
Backward (DB) 4.78±1.58 4.27±1.49 6.25±2.36 0.00*
CDI, cocaine-dependent individuals; CDI+ADHD, cocaine-dependent individuals with attention deficit/hyperactivity disorder; SD, Standard Deviation [±]; SCWT,
Stroop Color Word Test; sec, seconds; WCST, Wisconsin Card Sorting Test; WAIS-R, Wechsler Adult Intelligence Scale-Revised; *p<0.05 – statistically significant; p
values were calculated using ANOVA.
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FIGURE 1 | Neurocognitive performance of CDI, CDI+ADHD and healthy
controls in the six cognitive domains of the Frontal Assessment Battery
(FAB). CDI, cocaine-dependent individuals; ADHD, attention-deficit
hyperactivity disorder; FAB, Frontal Assessment Battery; ECF, executive
cognitive functioning; [*] indicate ECF domains significantly different between
groups by ANOVA (p<0.05); vertical lines represent standard errors SE (±).
controls (CDI+ADHD×Controls, p= 0.008; CDI×Controls,
p= 0.001).
We also found statistically significant differences in FAB’s
Conceptualization (F = 4.635, p= 0.012), FAB’s Mental flexibil-
ity (F = 3.678, p= 0.029) and in the total score of the FAB
(F = 7.992, p= 0.001). Post hoc analyses showed that the signif-
icant difference in Conceptualization was due to a worse per-
formance of CDI+ADHD when directly compared with the
normal controls (p= 0.010). Difference detected in Mental Flex-
ibility by ANOVA was associated with a lowered performance
of CDI compared to controls (p= 0.029, Figure 1). Finally, dif-
ferences among groups in the total’s FAB’s score were related
to a worse performance of both group of patients (CDI and
CDI+ADHD) when directly and separately compared with
controls (CDI+ADHD×Controls, p= 0.001; CDI×Controls,
p= 0.010).
CORRELATIONS OF COCAINE-USE VARIABLES AND CHILDHOOD ADHD
SCORES BY THE WURS WITH MEASURES OF EXECUTIVE FUNCTIONING
Associative analyses were conducted in order to investigate the
influence of the following variables associated with cocaine-use
and childhood ADHD symptoms on executive functioning: age at
onset of cocaine-use, duration of cocaine-use (in years), length of
abstinence from cocaine (in days), and WURS total scores.
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Table 4 | Correlation between drug use variables, childhoodADHD, and
neuropsychological measures among the CDI and CDI+ADHD.
Correlation (r s) Cocaine
age at
onset
(years)
Cocaine
lifetime
use
(years)
Cocaine
abstinence
length
(days)
Childhood
ADHD
(WURS)
NEUROPSYCHOLOGICAL MEASURES
FAB’s total score 0.016 0.015 −0.078 −0.285*
DF(WAIS-R) 0.138 0.015 −0.001 −0.286*
DB (WAIS-R) 0.045 −0.215 0.145 −0.014
CDI, cocaine-dependent individuals; CDI+ADHD, cocaine-dependent individuals
with attention deficit/hyperactivity disorder; rs, Spearman correlation coefficient;
FAB, Frontal Assessment Battery; DF, digits forward; DB, digits backward; WURS,
Wender-Utah Rating Scale; correlations were considered statistically significant
if *p<0.05.
Variables regarding cocaine-use were not correlated with exec-
utive functioning in this study. We found a significant negative
association between childhood ADHD symptoms as measured
by WURS and DF (r s=−0.286; p= 0.016) and WURS with the
FAB total score (r s=−0.285; p= 0.017). Correlations were ana-
lyzed considering both groups of patients together (CDI and
CDI+ADHD) (Table 4).
Additionally, considering the differences between samples,
between-group analysis of cognitive functioning was conducted
using Analysis of Covariance (ANCOVA) with age and gender as
covariates, and the results described above remained significant
(p< 0.05).
DISCUSSION
In this study, we evaluated CDI with and without a diagnosis of
ADHD, and compared them with healthy individuals. Our data
confirmed our previous studies (16, 17) indicating a poor exec-
utive functioning in CDI when compared with normal controls,
especially in a brief neuropsychological battery devised for evalu-
ation of prefrontal functioning (FAB) (17). Moreover, a previous
diagnosis of ADHD among CDI (CDI+ADHD) was associated
with a more pronounced negative impact on executive dysfunc-
tion, especially in tasks requiring attentional spam and abstraction
ability (concept formation). Our correlation analysis showed con-
sistency of these findings, since the self-reported presence of child-
hood symptoms of ADHD was negatively associated with actual
measures of attention and executive functions. Our findings con-
firm that ADHD symptoms have aggravating effects in executive
impairments in CDI and also suggest that the pre-existence of exec-
utive deficits (suggested by self-reported ADHD symptoms in the
childhood) may represent risk factors for a more intense degree of
cognitive impairment. Also, even CDI without ADHD presented
significant executive impairments, when compared with controls,
so cocaine per se may negatively interfere in brain functioning and
executive functioning.
The ECF deficits observed in CDI, in general, could support the
lack of self-control and persistence of compulsive behavior regard-
ing cocaine-use, despite of the adverse consequences on health
and social functioning (18, 52, 53). In other words, the inability
to change a previous behavior (mental flexibility deficits) and the
difficulty to acquire and maintain a healthier life-style (concep-
tualization and working memory deficits) might lead to social
dysfunction, treatment drop-outs, and relapses, which are often
observed in this population (18, 21–23).
Our findings support the idea that ADHD-related executive
dysfunction may represent a predisposing factor, which is brought
about by either genetic factors, or early environmental factors (e.g.,
emotional stress), which may negatively impact the normal devel-
opment of the PFC, which in turn leads to poor decision-making,
which heightens the risk for acquiring addictive disorders (18).
The literature is consistent with the hypothesis that ADHD play
a powerful role in increasing the likelihood of cocaine and other
substance abuse. ADHD symptoms could represent a critical risk
factor for cocaine-induced changes of the dopaminergic system
and brain alterations (54). The intermittent dopamine stimu-
lation that follows cocaine-use produces acute changes in the
synapses and in dopaminergic neurons in the PFC via the striato-
thalamo-frontal circuit associated with pleasure and reward (55).
In the long-term, cocaine-use may cause structural and functional
impairments in certain brain areas, including the PFC (4, 5, 52, 53),
representing an additional negative impact on PFC functioning in
these subjects (5, 18, 56).
In other words, while ADHD symptoms since the childhood
among cocaine abusers have been considered confounding fac-
tors for the neuropsychological evaluation, since ADHD per se is
associated to neuropsychological deficits affecting predominantly
ECF, ADHD-related symptoms may be an explaining sugges-
tive factor for the future development of cocaine dependence.
Much more than a “confounding factor,” ADHD might be an
“explaining factor” for the understanding of possible cognitive
endophenotypes associated with cocaine dependence. It is pos-
sible that CDI+ADHD would represent a subgroup of patients
whose cocaine-use may be associated with a certain type of “self-
treatment” for pre-existing ADHD symptoms (32). Also, it is
possible that another “subgroup” of CDI would present subclini-
cal ADHD symptoms (as they did not achieve the cutoff score in
WURS for ADHD, on the other side symptoms of ADHD in CDI
were two times more intense when compared with the control
group, p= 0.005), to which similar pharmacological and behav-
ioral strategies used for ADHD could be beneficial. For example,
a recent study showed that oral methylphenidate (MPH, which is
a traditional pharmacological treatment for ADHD) may induce
better performance (reducing errors) on the SCWT leading to a
more careful responding by reducing brain activity in the dorso-
lateral PFC of CDI as measured by fMRI (57). The authors argued
that MPH modulates dopamine in the PFC for both CDI and con-
trols, leading to a better error-related processing, with an effect
that is more significant in CDI (57). For CDI+ADHD, the use of
oral MPH could be very beneficial, considering that MPH-elicited
dopamine increases may improve ADHD symptoms and ventral
striatum functioning in adults with ADHD (58). In addition, it
could be also relevant to measure the role of other pharmacological
treatments, such as mood stabilizers to treat impulsivity and risky
behaviors in CDI+ADHD, CDI, and in other addicted patients
(59–61). The use of an indicated pharmacological treatment for
them could be beneficial, in order to help them to stop cocaine-use
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that may worsen a previous existent executive function deficit. The
abuse potential of each pharmacological treatment, however, is an
issue that should always be taken into account (61). Also, early
detection and treatment of ADHD in children seems to reduce the
risk for a later substance-use disorder (SUD) (62).
Other studies have suggested ECF deficits as possible cognitive
endophenotypes to addictive disorders (29, 63–65). Healthy adults
with family history of alcohol dependence presented more ECF
deficits, impulsivity traits (64), and also abnormal brain response
during a verbal working memory task (63) than individuals with-
out alcoholics in their families. A similar result was observed
in unaffected siblings of stimulants (cocaine and amphetamine)
dependents, which exhibited significantly lower ECF and response
control than healthy controls (66). After review the findings
from high-risk research, problem gamblers, and genetic associ-
ation studies, Verdejo-García et al. (67) concluded that impulsiv-
ity is a pre-existing vulnerability marker for SUDs. In fact, not
only impulsivity, but also risk-taking and stress responsivity (68)
could be cognitive and behavioral traits guided by genetic fac-
tors, constructed under certain environmental influences, which
could represent relevant factors on the vulnerability to addictive
disorders.
However, some limitations of this study need to be highlighted.
First, the present study included a small sample of CDI+ADHD,
but we have to bear in mind that our rigidity on criteria for the
diagnosis of ADHD was more appropriated to direct our analy-
sis. Second, since the present data are cross-sectional, it was not
possible to determine whether self-reported ADHD childhood
symptoms detected by WURS indeed afford a reliable method for
measuring ECF impairments in the childhood. On the other hand,
recent studies have shown that retrospective information pro-
vided by adults with ADHD has agreement with parents’ reports
(69). Also, our correlation analysis indicated a direct link between
previous ADHD symptoms and the actual executive dysfunc-
tion, suggesting that our data are in consonance with findings
that suggest an aggravating effect of ADHD symptoms on cog-
nitive dysfunction (19), but further prospective studies should
better investigate our hypothesis. Third, we evaluated samples
with different ages and genders, but the results remained signifi-
cant when including age and gender as covariates in all analysis.
Fourth, alcohol dependence was not an exclusion criteria and we
have previously suggested that alcohol use may be associated with
frontal lobes impairments (50), but it is unlikely that this may
have biased our results because we found a similar proportion
of patients with recent alcohol use in CDI and CDI+ADHD.
We believe that addicted patients independent of the used drug
could have different severities of frontal lobe functions, different
ADHD disturbances and different temperaments, so they need
specific treatment aims and different treatment strategies. Fifth,
it was not possible to determine the reversibility of executive
deficits, because the abstinence period in our sample was too
short, so future studies should investigate if executive dysfunc-
tion in CDI+ADHD and CDI could be reversible during cocaine
prolonged abstinence.
In summary, our data confirms that CDI+ADHD have more
pronounced neuropsychological alterations than CDI and con-
trols. Correlation analysis suggested that a possible pre-existing
executive dysfunction in CDI+ADHD could lead to a more salient
pattern of cognitive impairment and that it is a relevant candidate
to a possible cognitive endophenotype of cocaine dependence that
influences on later neuropsychological functioning. It remains to
be investigated by prospective studies if pre-morbid ECF-related
alterations would represent commonalities among the other sub-
stance or behavioral addictive disorders (i.e., gambling, sexual
compulsive behavior, among others) as well as their genetic and
neuroimaging underpinnings.
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